{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:02:07Z","timestamp":1779775327415,"version":"3.53.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"DOI":"10.1093\/ajhp\/zxaf340","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:09:04Z","timestamp":1765372144000},"page":"e432-e436","source":"Crossref","is-referenced-by-count":0,"title":["Confronting the undertreatment of opioid use disorder in pregnancy: From hesitation to action"],"prefix":"10.1093","volume":"83","author":[{"given":"Krystal K C","family":"Riccio","sequence":"first","affiliation":[{"name":"Roseman University of Health Sciences, College of Pharmacy , Henderson, NV , , Las Vegas, NV ,","place":["USA"]},{"name":"and Behavioral Health Group, Desert Inn Treatment Center , Henderson, NV , , Las Vegas, NV ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"21","key":"2026052601021066400_zxaf340-B1","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1001\/jama.2022.17045","article-title":"US trends in drug overdose mortality among pregnant and postpartum persons, 2017-2020","volume":"328","author":"Bruzelius","year":"2022","journal-title":"JAMA"},{"key":"2026052601021066400_zxaf340-B2","article-title":"How the U.S. can better understand\u2014and prevent\u2014maternal deaths related to substance use","author":"Amodio"},{"issue":"1","key":"2026052601021066400_zxaf340-B3","doi-asserted-by":"publisher","first-page":"e2453303","DOI":"10.1001\/jamanetworkopen.2024.53303","article-title":"Severe maternal morbidity among pregnant people with opioid use disorder enrolled in Medicaid","volume":"8","author":"Auty","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026052601021066400_zxaf340-B4","article-title":"Opioid use disorder and treatment among pregnant and postpartum Medicaid enrollees","author":"Roberts"},{"key":"2026052601021066400_zxaf340-B5","doi-asserted-by":"publisher","first-page":"100239","DOI":"10.1016\/j.dadr.2024.100239","article-title":"Prevalence and predictors of medication for opioid use disorder among reproductive-aged women","volume":"11","author":"Bello","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"key":"2026052601021066400_zxaf340-B6","doi-asserted-by":"publisher","first-page":"209289","DOI":"10.1016\/j.josat.2024.209289","article-title":"Timing of treatment for opioid use disorder among birthing people","volume":"161","author":"Kim","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"5","key":"2026052601021066400_zxaf340-B7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/ADM.0000000000000780","article-title":"Healthcare patterns of pregnant women and children affected by OUD in 9 state Medicaid populations","volume":"15","author":"Jarlenski","year":"2021","journal-title":"J Addict Med"},{"issue":"22","key":"2026052601021066400_zxaf340-B8","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1001\/jama.2020.8020","article-title":"Screening for unhealthy drug use: US Preventive Services Task Force recommendation statement","volume":"323","author":"US Preventive Services Task Force","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"2026052601021066400_zxaf340-B9","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711","volume":"130","author":"American College of Obstetricians and Gynecologists","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2026052601021066400_zxaf340-B10","author":"National Institute on Drug Abuse"},{"key":"2026052601021066400_zxaf340-B11","volume-title":"Screening for Unhealthy Drug Use in Primary Care in Adolescents and Adults, Including Pregnant Persons: Updated Systematic Review for the U.S. Preventive Services Task Force","author":"Patnode","year":"2020"},{"issue":"12","key":"2026052601021066400_zxaf340-B12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/sj.jp.7211823","article-title":"Validation of the 4P\u2019s Plus screen for substance use in pregnancy","volume":"27","author":"Chasnoff","year":"2007","journal-title":"J Perinatol"},{"issue":"2S suppl 1","key":"2026052601021066400_zxaf340-B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ADM.0000000000000633","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","author":"American Society of Addiction Medicine","year":"2020","journal-title":"J Addict Med"},{"issue":"22","key":"2026052601021066400_zxaf340-B14","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","article-title":"Buprenorphine versus methadone for opioid use disorder in pregnancy","volume":"387","author":"Suarez","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"2026052601021066400_zxaf340-B15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/reprodmed2040019","article-title":"Outcomes of neonates exposed to buprenorphine versus methadone in utero: a systematic review and meta-analysis","volume":"2","author":"Christianson","year":"2021","journal-title":"Reprod Med"},{"issue":"9","key":"2026052601021066400_zxaf340-B16","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1080\/10826084.2022.2083174","article-title":"Buprenorphine compared with methadone in pregnancy: a systematic review and meta-analysis","volume":"57","author":"Kinsella","year":"2022","journal-title":"Subst Use Misuse"},{"issue":"7","key":"2026052601021066400_zxaf340-B17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin Perinatol"},{"key":"2026052601021066400_zxaf340-B18","volume-title":"The ASAM Principles of Addiction Medicine","author":"Karan","year":"2024","edition":"7th ed"},{"issue":"2","key":"2026052601021066400_zxaf340-B19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1360-0443.2006.01321.x","article-title":"Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"key":"2026052601021066400_zxaf340-B20","volume-title":"Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy","author":"World Health Organization","year":"2014"},{"issue":"3","key":"2026052601021066400_zxaf340-B21","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1097\/ADM.0000000000000909","article-title":"Differential gateways, facilitators, and barriers to substance use disorder treatment for pregnant women and mothers: a scoping systematic review","volume":"16","author":"Choi","year":"2022","journal-title":"J Addict Med"},{"key":"2026052601021066400_zxaf340-B22","doi-asserted-by":"publisher","first-page":"107652","DOI":"10.1016\/j.drugalcdep.2019.107652","article-title":"Treatment for substance use disorders in pregnant women: motivators and barriers","volume":"205","author":"Frazer","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"2026052601021066400_zxaf340-B23","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1002\/phar.1846","article-title":"The 2016 ACCP pharmacotherapy didactic curriculum toolkit","volume":"36","author":"Schwinghammer","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"6","key":"2026052601021066400_zxaf340-B24","doi-asserted-by":"publisher","first-page":"100061","DOI":"10.1016\/j.ajpe.2023.100061","article-title":"Opioid use disorder curricular content in US-based doctor of pharmacy programs","volume":"87","author":"Nichols","year":"2023","journal-title":"Am J Pharm Educ"},{"key":"2026052601021066400_zxaf340-B25","volume-title":"Rapid Response Request: Substance Use Disorder Curricula in Medical, Nursing, and Physician Assistant Schools","author":"Gaiser","year":"2021"},{"key":"2026052601021066400_zxaf340-B26","author":"Substance Abuse and Mental Health Services Administration"},{"key":"2026052601021066400_zxaf340-B27","author":"Substance Abuse and Mental Health Services Administration"},{"key":"2026052601021066400_zxaf340-B28","volume-title":"Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants","author":"Substance Abuse and Mental Health Services Administration","year":"2018"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf340\/65848218\/zxaf340.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/11\/e432\/65848218\/zxaf340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/11\/e432\/65848218\/zxaf340.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:02:18Z","timestamp":1779771738000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/11\/e432\/8377525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,12,11]]},"published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf340","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,1]]},"published":{"date-parts":[[2025,12,11]]}}}